Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Climb Bio, Inc. (CLYM) had Free Cash Flow per Share of $-0.21 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.72M |
|
-- |
|
-- |
|
$15.21M |
|
$-15.21M |
|
$1.49M |
|
$-13.72M |
|
$-13.72M |
|
$-13.72M |
|
$-13.72M |
|
$-13.72M |
|
$-13.72M |
|
$-15.21M |
|
$-15.48M |
|
68.21M |
|
68.21M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$113.40M |
|
$0.25M |
|
$38.97M |
|
$152.37M |
|
$4.07M |
|
-- |
|
$0.22M |
|
$4.29M |
|
$148.09M |
|
$148.09M |
|
$148.09M |
|
47.77M |
|
| Cash Flow Statement Financials | |
$-14.38M |
|
$-12.96M |
|
$0.01M |
|
$35.69M |
|
$8.36M |
|
$-27.33M |
|
$1.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.27% |
|
-9.27% |
|
-9.01% |
|
-9.27% |
|
$3.10 |
|
|
Free Cash Flow per Share |
$-0.21 |
$-0.21 |
|